Get Premium to unlock powerful stock data

Boxer Capital, Llc Buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, Sells Seagen Inc, Amarin Corp PLC, Therapeutics Acquisition Corp

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
Investment company Boxer Capital, Llc (Current Portfolio) buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, Fulcrum Therapeutics Inc, Turning Point Therapeutics Inc, sells Seagen Inc, Amarin Corp PLC, Therapeutics Acquisition Corp, Kadmon Holdings Inc, Agenus Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Boxer Capital, Llc. As of 2021Q3, Boxer Capital, Llc owns 88 stocks with a total value of $2.9 billion. These are the details of the buys and sells.

For the details of BOXER CAPITAL, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/boxer+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of BOXER CAPITAL, LLC
  1. Mirati Therapeutics Inc (MRTX) - 2,000,000 shares, 12.36% of the total portfolio.
  2. BeiGene Ltd (BGNE) - 764,188 shares, 9.69% of the total portfolio.
  3. SpringWorks Therapeutics Inc (SWTX) - 2,075,905 shares, 4.60% of the total portfolio.
  4. ITeos Therapeutics Inc (ITOS) - 4,345,016 shares, 4.10% of the total portfolio.
  5. Tyra Biosciences Inc (TYRA) - 6,323,359 shares, 3.88% of the total portfolio. New Position
New Purchase: Tyra Biosciences Inc (TYRA)

Boxer Capital, Llc initiated holding in Tyra Biosciences Inc. The purchase prices were between $16.91 and $26, with an estimated average price of $19.11. The stock is now traded at around $27.600000. The impact to a portfolio due to this purchase was 3.88%. The holding were 6,323,359 shares as of 2021-09-30.

New Purchase: Tango Therapeutics Inc (TNGX)

Boxer Capital, Llc initiated holding in Tango Therapeutics Inc. The purchase prices were between $9.56 and $17.3, with an estimated average price of $13.13. The stock is now traded at around $13.500000. The impact to a portfolio due to this purchase was 3.1%. The holding were 6,871,642 shares as of 2021-09-30.

New Purchase: Blueprint Medicines Corp (BPMC)

Boxer Capital, Llc initiated holding in Blueprint Medicines Corp. The purchase prices were between $80.98 and $109.47, with an estimated average price of $93.09. The stock is now traded at around $115.360000. The impact to a portfolio due to this purchase was 1.53%. The holding were 425,000 shares as of 2021-09-30.

New Purchase: Fulcrum Therapeutics Inc (FULC)

Boxer Capital, Llc initiated holding in Fulcrum Therapeutics Inc. The purchase prices were between $7.28 and $30.97, with an estimated average price of $18.95. The stock is now traded at around $17.930000. The impact to a portfolio due to this purchase was 1.23%. The holding were 1,250,000 shares as of 2021-09-30.

New Purchase: Turning Point Therapeutics Inc (TPTX)

Boxer Capital, Llc initiated holding in Turning Point Therapeutics Inc. The purchase prices were between $61 and $81.99, with an estimated average price of $71.44. The stock is now traded at around $44.410000. The impact to a portfolio due to this purchase was 1.22%. The holding were 525,000 shares as of 2021-09-30.

New Purchase: Iovance Biotherapeutics Inc (IOVA)

Boxer Capital, Llc initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $19.660000. The impact to a portfolio due to this purchase was 0.95%. The holding were 1,100,000 shares as of 2021-09-30.

Added: Kinnate Biopharma Inc (KNTE)

Boxer Capital, Llc added to a holding in Kinnate Biopharma Inc by 73.33%. The purchase prices were between $17.81 and $24.87, with an estimated average price of $21.83. The stock is now traded at around $22.120000. The impact to a portfolio due to this purchase was 0.63%. The holding were 1,847,559 shares as of 2021-09-30.

Added: Centessa Pharmaceuticals PLC (CNTA)

Boxer Capital, Llc added to a holding in Centessa Pharmaceuticals PLC by 47.55%. The purchase prices were between $16.7 and $23.11, with an estimated average price of $20.76. The stock is now traded at around $12.540000. The impact to a portfolio due to this purchase was 0.25%. The holding were 1,334,227 shares as of 2021-09-30.

Sold Out: Seagen Inc (SGEN)

Boxer Capital, Llc sold out a holding in Seagen Inc. The sale prices were between $142.45 and $169.82, with an estimated average price of $155.61.

Sold Out: Amarin Corp PLC (AMRN)

Boxer Capital, Llc sold out a holding in Amarin Corp PLC. The sale prices were between $3.94 and $5.84, with an estimated average price of $4.91.

Sold Out: Therapeutics Acquisition Corp (RACA)

Boxer Capital, Llc sold out a holding in Therapeutics Acquisition Corp. The sale prices were between $10.27 and $10.27, with an estimated average price of $10.27.

Sold Out: Kadmon Holdings Inc (KDMN)

Boxer Capital, Llc sold out a holding in Kadmon Holdings Inc. The sale prices were between $3.55 and $9.09, with an estimated average price of $5.66.

Sold Out: Agenus Inc (AGEN)

Boxer Capital, Llc sold out a holding in Agenus Inc. The sale prices were between $4.98 and $6.63, with an estimated average price of $5.76.

Sold Out: Biomarin Pharmaceutical Inc (BMRN)

Boxer Capital, Llc sold out a holding in Biomarin Pharmaceutical Inc. The sale prices were between $74.77 and $85.47, with an estimated average price of $79.09.



Here is the complete portfolio of BOXER CAPITAL, LLC. Also check out:

1. BOXER CAPITAL, LLC's Undervalued Stocks
2. BOXER CAPITAL, LLC's Top Growth Companies, and
3. BOXER CAPITAL, LLC's High Yield stocks
4. Stocks that BOXER CAPITAL, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus